Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors
13 nov. 2009 10h01 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Reports Third Quarter Financial Results
11 nov. 2009 16h20 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex: GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Host Third Quarter and Nine Months 2009 Financial Results Conference Call on Thursday, November 12, 2009
30 oct. 2009 10h48 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present at the 8th Annual Bio Investor Forum
27 oct. 2009 08h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present At Growth Stock Conference Hosted by Security Research Associates, Inc.
15 oct. 2009 10h36 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Enters License Agreement With Millennia Holdings for Exclusive Rights to the AutoloGel System in Japan
30 sept. 2009 10h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix CEO Issues Shareholder Update
09 sept. 2009 08h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 9, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer, Martin Rosendale, issued the following letter to shareholders providing...
Cytomedix Announces Subsequent and Final Closing of Registered Direct Offering of Common Stock and Warrants
27 août 2009 08h30 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Registered Direct Offering of Common Stock and Warrants
12 août 2009 09h01 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 12, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Second Quarter Financial Results Feature Product Sales Up 72% Over First Quarter
10 août 2009 09h50 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...